Clinical Trial Update: HLA Demographics Study in Adults With Type 1 Diabetes

View source ↗

Summary

GentiBio, Inc. is conducting a HLA demographics study in adults with Type 1 diabetes mellitus, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Snippet

Sponsor: GentiBio, Inc | Conditions: Diabetes Mellitus, Type I | Status: RECRUITING